HOPO Therapeutics named as an awardee in CLS Inspire QuickFire Challenge for BIPOC Communities

Johnson & Johnson Innovation LLC, together with California Life Sciences (CLS) and AbbVie, has selected HOPO Therapeutics as an awardee of the CLS Inspire QuickFire Challenge for BIPOC Communities . This QuickFire Challenge recognizes innovative companies that are focusing on addressing healthcare disparities that impact historically excluded communities in the United States. As part of the award, HOPO Therapeutics receives grant funding and a year of complimentary membership to CLS.

HOPO’s mission is to develop treatments for heavy metal poisoning, a decades-old public health crisis that disproportionately impacts low-income communities of color around the world. We are so grateful to the teams at Johnson & Johnson Innovation, AbbVie, and CLS for supporting us in this mission.